<DOC>
	<DOCNO>NCT03018366</DOCNO>
	<brief_summary>The purpose study determine whether low estrogen level young woman hypothalamic amenorrhea ( premenopausal HypoE ) associate risk factor cardiovascular disease . For study , investigator measure vascular function immune marker : - young woman hypothalamic amenorrhea ( &gt; 3 month menstrual cycle due low estrogen ) - young woman regular menstrual cycle hormone therapy . - recently menopausal woman ( &lt; 3 year final menstrual period ) hormone therapy . Premenopausal HypoE participant randomize use either estrogen patch placebo patch ( active medicine ) 3 month , follow estrogen placebo patch plus progesterone placebo pills 2 additional week . The investigator look see estrogen improves vascular immune function .</brief_summary>
	<brief_title>Atherosclerosis , Immune Mediated Inflammation Hypoestrogenemia Young Women</brief_title>
	<detailed_description>Study Aims : 1 . To test hypothesis premenopausal HypoE associate pre-clinical CVD determine reduction vascular endothelial function increase central arterial stiffness . 2 . To test hypothesis premenopausal HypoE associate increase immune-mediated inflammation . 3 . To test hypothesis estrogen reduce inflammation , improve vascular endothelial function central arterial stiffness premenopausal HypoE woman . In randomized , double-blind placebo-controlled trial premenopausal HypoE woman investigator test 12 week transdermal estradiol 0.1 mg/day patch placebo follow 2 week estradiol plus progesterone 200mg vascular endothelial function , arterial stiffness immune-mediated inflammation versus placebo . Patches apply participant low abdomen twice weekly , alternate side . The investigator use non-invasive test measure vascular function include : - Peripheral arterial tonometry ( PAT ) - SphygmoCor measurement central blood pressure - Carotid intima-media thickness ( CIMT )</detailed_description>
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Atherosclerosis</mesh_term>
	<mesh_term>Amenorrhea</mesh_term>
	<mesh_term>Estradiol</mesh_term>
	<mesh_term>Polyestradiol phosphate</mesh_term>
	<mesh_term>Estrogens</mesh_term>
	<mesh_term>Progesterone</mesh_term>
	<mesh_term>Estradiol 3-benzoate</mesh_term>
	<mesh_term>Estradiol 17 beta-cypionate</mesh_term>
	<mesh_term>Estradiol valerate</mesh_term>
	<criteria>For premenopausal Hypo E normal control woman inclusion include : Premenopausal currently hormone therapy , English speaking ( purpose complete psychosocial assessment ) able give inform consent gynecological age ( age since menarche ) &gt; 10 &lt; 25 year , chronological age &gt; 18 year Within 90110 % ideal body weight determined 1983 Metropolitan height weight table woman All participant hypothalamic amenorrhea diagnose base exclusion etiology amenorrhea , include pregnancy , thyroid dysfunction , hyperprolactinemia , premature ovarian insufficiency , polycystic ovary disease For recently menopausal woman inclusion include : Follicle stimulate hormone ( FSH ) &gt; 30 12 month amenorrhea,92 within 3 year final menstrual period natural menopausal hormone therapy English speaking Able give inform consent Within 90110 % ideal body weight For premenopausal Hypo E normal control woman exclusion include : Smoking Hypertension Hyperlipidemia Diabetes Medications include psychotropic illicit drug , medical , neurological Ophthalmologic disease except acuity problem Major Axis I disorder depression Pregnancy last 12 month and/or lactate last 6 month Current use hormone contraceptive estrogen progestin therapy For HypoE woman , exclusion criterion include : Allergy peanut Allergy adhesive tape For recently menopausal woman exclusion also include : Previous current use hormone therapy , estrogen progestin Surgical chemotherapy induce menopause Premature ovarian failure</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>estrogen</keyword>
	<keyword>premenopause</keyword>
	<keyword>menopause</keyword>
	<keyword>amenorrhea</keyword>
</DOC>